$SIBN: PrinterPrezz to Work With SI-BONE to Speed Innovation in Metal 3D …

Date: Tuesday, February 12th, 2019

Stock(s) mentioned:

Source: Business Wire (https://www.businesswire.com)

Summary: … to design and manufacture next generation medical devices, today announced that it has signed a customer agreement with SI-BONE, Inc. (NASDAQ: SIBN), …

Full article address: https://www.businesswire.com/news/home/20190212005304/en/PrinterPrezz-Work-SI-BONE-Speed-Innovation-Metal-3D

Related News:

$SIBN: SI-BONE’s (SIBN) CEO Jeff Dunn on Q1 2019 Results – Earnings …

$HMLP $SIBN $FLIC: Were Hedge Funds Right About Flocking Into Hoegh LNG Partners …

$LBC $FELP $SIBN: Here’s What Hedge Funds Think About Luther Burbank Corporation …

$SIBN: SI-BONE receives FDA clearance for iFuse Bedrock technology

$SIBN: SI-BONE, Inc. (SIBN) CEO Jeffrey Dunn on Q4 2018 Results …

$SIBN: SI-BONE to Present at the 37th Annual JP Morgan Healthcare …

$SIBN: AZ BCBS to cover SI-BONE iFuse Implant for MIS-SI joint fusion

$SIBN: SI-BONE To Report Third Quarter Financial Results on November …

$SIBN: SI-BONE Announces Pricing of Initial Public Offering

Latest News:

$DAL $ALK $LUV $NFLX $UAL: Delta’s test of free in-flight Wi-Fi may shame other airlines into offering service

$AVTR $FSLY $LK $LYFT $PINS $UBER: Why the IPO Boom Will Continue

$SBUX: Millions of Americans Could Miss Work Tomorrow After the ‘Game of Thrones’ Finale

$AMZN $OXY $APC $WFC $SRE: Want to invest like Warren Buffett? Here are the ins and outs of buying preferred stock

$TSLA $GM: Tesla fires could dampen electric car sales as industry ramps up EV production, auto analysts say

$ROKU $GH $CVNA: 3 Stocks That Have Doubled in 2019 — Are They Still Buys?

$AXSM: Here’s Why You’ll Regret Ignoring This Biotech Stock Rocket

$MMM: Market Loses Its Hopium-Induced High, Falls 4 Weeks Straight

$TLRY $ACB: How Did Tilray Stack Up to the Competition?

$BAH: Booz Allen Has Been a Big Winner, but the Best May Be Yet to Come

$ICPT $GILD: Better Buy: Intercept Pharmaceuticals vs. Gilead Sciences